Please use this identifier to cite or link to this item:
Title: Highly Active Antiretroviral Therapy (HAART)–plus: next steps to enhance HAART in resource-limited areas
Authors: Flanigan, Timothy P.
Kaloustain, Kara Wools
Harwell, Joseph
Cu-Uvin, Susan
Kimaiyo, Sylvester
Carter, Jane E.
Keywords: antiretroviral therapy
Issue Date: Jun-2007
Publisher: Infectious Diseases Society of America
Abstract: HAART has been extremely successful in suppressing HIV infection, restoring im- mune function, and improving health, and it has led to dramatic decreases in morbidity and mortality in those areas of the developing world where HIV infection is most prevalent. Studies from the ART in Lower Income Countries cohort and from Malawi, Uganda, Cote de’Ivoire, and India have clearly demonstrated that 1 75% of HIV-infected individuals who re- ceive fixed-dose combination (FDC) ther- apy with a nonnucleoside reverse-tran- scriptase inhibitor have excellent viral suppression [1–5]. These successes have been outstanding and have driven the scale-up of HAART as a global health priority. More than 2 million individuals in the developing world are receiving HAART; most of these individuals are in sub-Saharan Africa, which bears the brunt of the HIV epidemic. The successful development of HIV care programs to deliver HAART faces
Appears in Collections:School of Medicine

Files in This Item:
File Description SizeFormat 
FlaniganTimothy P..pdf86.98 kBAdobe PDFThumbnail

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.